PIQRAY 250 MG Daily Dose Pack

RxCUI: 2169320
RxNorm name: PIQRAY 250 MG Daily Dose Pack
Display name: PIQRAY 250 MG Daily Dose Pack
Full name: PIQRAY 250 MG Daily Dose Pack
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PIQRAY	ALPELISIB	Novartis Pharmaceuticals Corporation	b20b4e18-7a4b-4500-a08f-06c6dab0ee5b	2025-12-15	Warnings, Adverse reactions	Exact identifier rxcui: 2169320

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
b20b4e18-7a4b-4500-a08f-06c6dab0ee5b	PIQRAY 250 MG Daily Dose Pack	PSN	13	These highlights do not include all the information needed to use PIQRAY safely and effectively. See full prescribing information for PIQRAY. PIQRAY ® (alpelisib) tablets, for oral use Initial U.S. Approval: 2019	20251215
b20b4e18-7a4b-4500-a08f-06c6dab0ee5b	Piqray 250 MG Daily Dose Pack	SY	13	These highlights do not include all the information needed to use PIQRAY safely and effectively. See full prescribing information for PIQRAY. PIQRAY ® (alpelisib) tablets, for oral use Initial U.S. Approval: 2019	20251215
b20b4e18-7a4b-4500-a08f-06c6dab0ee5b	{28 (alpelisib 200 MG Oral Tablet [Piqray]) / 28 (alpelisib 50 MG Oral Tablet [Piqray]) } Pack [Piqray 250 MG Daily Dose]	BPCK	13	These highlights do not include all the information needed to use PIQRAY safely and effectively. See full prescribing information for PIQRAY. PIQRAY ® (alpelisib) tablets, for oral use Initial U.S. Approval: 2019	20251215